high-dose recombinant interferon a-2B

BIOLOGICAL2 trials

Sponsors

Shanghai Junshi Bioscience Co., Ltd., Innovent Biologics (Suzhou) Co. Ltd.

Conditions

Acral Melanoma That Has Been Removed by SurgeryMucosal Melanoma

Phase 2

The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery

TerminatedNCT03178123

Shanghai Junshi Bioscience Co., Ltd.Mucosal Melanoma

Start: 2017-05-31End: 2019-06-30Updated: 2026-07-27

Phase 3

The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery

TerminatedNCT04277663

Innovent Biologics (Suzhou) Co. Ltd.Acral Melanoma That Has Been Removed by Surgery

Start: 2020-04-17End: 2023-02-28Updated: 2023-03-09

Related Papers

Adjuvant anti-PD-1 ab (Toripalimab) versus high-dose IFN-a2b in resected mucosal melanoma: A phase randomized trial.

Journal of Clinical Oncology2021-05-204 citations

Abstract IA16: The landscape of mucosal melanoma: A long way to go

Cancer Research2020-10-01